Back to Search Start Over

Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly

Authors :
Francisco J. Tinahones
Eva Venegas-Moreno
Juan Francisco Martín-Rodríguez
Pedro Benito-López
Alfonso Soto-Moreno
María Ángeles Gálvez
Ainara Madrazo-Atutxa
David A. Cano
Alfonso Leal-Cerro
Elena Torres-Vela
Junta de Andalucía
Ministerio de Ciencia e Innovación (España)
Novartis
Universidad de Sevilla. Departamento de Medicina
Universidad de Sevilla. Departamento de Psicología Experimental
Source :
idUS. Depósito de Investigación de la Universidad de Sevilla, instname, PLoS ONE, idUS: Depósito de Investigación de la Universidad de Sevilla, Universidad de Sevilla (US), Digital.CSIC. Repositorio Institucional del CSIC, PLoS ONE, Vol 8, Iss 4, p e60041 (2013)
Publication Year :
2013
Publisher :
Public Library of Science, 2013.

Abstract

Patients with active untreated acromegaly show mild to moderate neurocognitive disorders that are associated to chronic exposure to growth hormone (GH) and insulin-like growth factor (IGF-I) hypersecretion. However, it is unknown whether these disorders improve after controlling GH/IGF-I hypersecretion. The aim of this study was to compare neurocognitive functions of patients who successfully underwent GH-secreting adenoma transsphenoidal surgery (cured patients) with patients with naive acromegaly. In addition, we wanted to determine the impact of different clinical and biochemical variables on neurocognitive status in patients with active disease and after long-term cure. A battery of six standardized neuropsychological tests assessed attention, memory and executive functioning. In addition, a quantitative electroencephalography with Low-Resolution Electromagnetic Tomography (LORETA) solution was performed to obtain information about the neurophysiological state of the patients. Neurocognitive data was compared to that of a healthy control group. Multiple linear regression analysis was also conducted using clinical and hormonal parameters to obtain a set of independent predictors of neurocognitive state before and after cure. Both groups of patients scored significantly poorer than the healthy controls on memory tests, especially those assessing visual and verbal recall. Patients with cured acromegaly did not obtain better cognitive measures than naïve patients. Furthermore memory deficits were associated with decreased beta activity in left medial temporal cortex in both groups of patients. Regression analysis showed longer duration of untreated acromegaly was associated with more severe neurocognitive complications, regardless of the diagnostic group, whereas GH levels at the time of assessment was related to neurocognitive outcome only in naïve patients. Longer duration of post-operative biochemical remission of acromegaly was associated with better neurocognitive state. Overall, this data suggests that the effects of chronic exposure to GH/IGF-I hypersecretion could have long-term effects on brain functions. © 2013 Martín-Rodríguez et al.<br />Funding for this project was provided by an R&D grant from Novartis Oncology and the Plan Andaluz de Investigación (CTS-444). DAC was supported by the “Ramón y Cajal” program (RYC-2006-001071) of the Spanish Ministry of Science and Innovation.

Details

Database :
OpenAIRE
Journal :
idUS. Depósito de Investigación de la Universidad de Sevilla, instname, PLoS ONE, idUS: Depósito de Investigación de la Universidad de Sevilla, Universidad de Sevilla (US), Digital.CSIC. Repositorio Institucional del CSIC, PLoS ONE, Vol 8, Iss 4, p e60041 (2013)
Accession number :
edsair.doi.dedup.....24ef9696c81c50469aaa58ba6b3009e9